These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33959979)

  • 21. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation.
    Senapati P; Dey S; Sudarshan D; Das S; Kumar M; Kaypee S; Mohiyuddin A; Kodaganur GS; Kundu TK
    FEBS J; 2018 Sep; 285(18):3503-3524. PubMed ID: 30085406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleophosmin and cancer.
    Grisendi S; Mecucci C; Falini B; Pandolfi PP
    Nat Rev Cancer; 2006 Jul; 6(7):493-505. PubMed ID: 16794633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health and Fitness at the Single-Cell Level.
    Green DR
    Cancer Immunol Res; 2021 Feb; 9(2):130-135. PubMed ID: 33536268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
    Falini B
    Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
    Du Pisani LA; Shires K
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-organ transcriptome variation across 21 cancer types.
    Hu W; Yang Y; Li X; Zheng S
    Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
    Wooten DJ; Quaranta V
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin A2: its molecular regulation and cellular expression in cancer development.
    Wang CY; Lin CF
    Dis Markers; 2014; 2014():308976. PubMed ID: 24591759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
    Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
    J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecules that target nucleophosmin for cancer treatment: an update.
    Di Matteo A; Franceschini M; Chiarella S; Rocchio S; Travaglini-Allocatelli C; Federici L
    Oncotarget; 2016 Jul; 7(28):44821-44840. PubMed ID: 27058426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KLF2 transcription suppresses endometrial cancer cell proliferation, invasion, and migration through the inhibition of NPM1.
    Cheng X; Shen C; Liao Z
    J Obstet Gynaecol; 2023 Dec; 43(2):2238827. PubMed ID: 37610103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.
    Jeong EG; Lee SH; Yoo NJ; Lee SH
    APMIS; 2007 Apr; 115(4):341-6. PubMed ID: 17504301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
    Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
    Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.